GURUFOCUS.COM » STOCK LIST » Technology » Software » Neurones (STU:NE9) » Definitions » EBIT

Neurones (STU:NE9) EBIT : €82.7 Mil (TTM As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Neurones EBIT?

Neurones's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was €42.5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was €82.7 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Neurones's annualized ROC % for the quarter that ended in Jun. 2024 was 24.17%. Neurones's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 142.97%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Neurones's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 9.66%.


Neurones EBIT Historical Data

The historical data trend for Neurones's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurones EBIT Chart

Neurones Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.16 54.58 62.73 74.57 82.20

Neurones Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.67 36.89 41.97 40.23 42.50

Competitive Comparison of Neurones's EBIT

For the Information Technology Services subindustry, Neurones's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurones's EV-to-EBIT Distribution in the Software Industry

For the Software industry and Technology sector, Neurones's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Neurones's EV-to-EBIT falls into.



Neurones EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €82.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurones  (STU:NE9) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Neurones's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=74.618 * ( 1 - 30.11% )/( (195.951 + 235.624)/ 2 )
=52.1505202/215.7875
=24.17 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=674.251 - 180.542 - ( 297.758 - max(0, 228.923 - 545.813+297.758))
=195.951

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=679.445 - 175.706 - ( 268.115 - max(0, 243.406 - 546.347+268.115))
=235.624

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Neurones's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=85.004/( ( (58.725 + max(-1.047, 0)) + (60.187 + max(-10.834, 0)) )/ 2 )
=85.004/( ( 58.725 + 60.187 )/ 2 )
=85.004/59.456
=142.97 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(174.301 + 0.709 + 39.81) - (180.542 + 0 + 35.325)
=-1.047

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(175.163 + 2.066 + 38.75) - (175.706 + 0 + 51.107)
=-10.834

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Neurones's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=82.734/856.333
=9.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurones EBIT Related Terms

Thank you for viewing the detailed overview of Neurones's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurones Business Description

Traded in Other Exchanges
Address
Immeuble Le Clemenceau 1 - 205, Avenue Georges Clemenceau, Nanterre Cedex, Paris, FRA, 92024
Neurones SA is a France-based technology sector company. Its core business involves the provision of Information Technology (IT) services catering to the needs of hardware, software, and consulting. Its operations are thereby divided into three segments: Infrastructure Services, Application Services, and Consulting. The Infrastructure segment is the strongest revenue driver through the provision of such services as IT operations, IT service management, systems and network, server, application, and workstation outsourcing. Its second most profitable business is carried out through the Application segment, which entails SAP, Web and decision support, social media, data analysis.

Neurones Headlines

No Headlines